Navigation

Press releases

The NICE press team issues press releases on all published Clinical Guidelines, Technology Appraisals, and Public Health guidance, as well as for consultations on draft guidance and other news from NICE. Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please send an email to pressoffice@nice.org.uk or call the press team on 0845 003 7782.

Results 61-70 of 859

NICE: Diagnosing and treating prostate cancer
Newly updated NICE guidance on how best to diagnose and treat prostate cancer will help doctors to ensure that men are given information about the treatment options available and help in choosing the best option to suit them.
January 8, 2014

NICE launches consultation on 2015/16 QOF
NICE, the health and social care guidance body, has opened a public consultation today on potential new indicators for the 2015/16 Quality and Outcomes Framework (QOF). The potential new indicators have been developed to improve the quality of care provided by family doctors.
January 6, 2014

NICE issues guidance to encourage people to make resolutions for life, not just New Year
After Christmas and New Year, many of us are determined to drink less, quit smoking, do more exercise or eat healthier, but it becomes overwhelming and our resolve crumbles. This new guidance from NICE is aimed at one simple idea: helping people to live healthier lives by ensuring that health and social care budgets are spent on activities that work.
January 2, 2014

NICE gives green light to treatment for macular oedema in final draft guidance
The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending aflibercept solution for injection (Eylea, Bayer) as an option for treating visual impairment caused by macular oedema, a condition which affects a person?s ability to see detail and colour.
December 31, 2013

NICE says yes to non-Hodgkin's lymphoma treatment in final draft guidance
Draft guidance from NICE says the drug pixantrone should be funded by the NHS to treat certain people with aggressive non-Hodgkin?s B-cell lymphoma.
December 31, 2013

NICE draft guidance recommends another treatment for prostate cancer
NICE has issued new draft guidance recommending degarelix as an option for treating prostate cancer in people with spinal metastases who are at risk of impending spinal cord compression.
December 27, 2013

NICE consults on ustekinumab for psoriatic arthritis
The National Institute for Health and Care Excellence (NICE) has opened a consultation on draft guidance for ustekinumab (Stelara), a drug licensed to treat active psoriatic arthritis.
December 24, 2013

NICE guidance supports new device used in treating complex disease of the main heart artery
NICE, the guidance and standards body, today (18 December), publishes positive final medical technology guidance on the use of a device for treating bulging blood vessels and tears in the wall of the main artery carrying blood from the heart to the body.
December 18, 2013

NICE aims to drive up standards of care with new advice to improve mental wellbeing of older people in care homes
With the number of older people in the UK set to rise to 16 million over the next 20 years and more people living longer than ever before, NICE is advising that services should be configured to ensure they receive excellent care and support.
December 12, 2013

NICE to produce new Medtech Innovation Briefings
The National Institute for Health and Care Excellence (NICE) is to start developing Medtech Innovation Briefings ? a new product to support healthcare staff considering using new medical devices and other medical technologies.
December 10, 2013

This page was last updated: 23 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.